
Industry: Medical Instruments & Supplies
Sector: Healthcare
Primary metal: None
Zentek Ltd. is an ISO 13485-certified intellectual property development and commercialization company headquartered in Guelph, Ontario, Canada, that specializes in nanotechnology and advanced materials. Operating as a portfolio of complementary businesses, Zentek develops and commercializes three core brands: ZenGUARD™, a graphene-based antimicrobial coating technology applied to surgical masks and HVAC filters to enhance viral filtration efficiency; Triera Biosciences, a wholly owned biotech brand built on an exclusive aptamer platform for rapid therapeutic development targeting infectious diseases; and Albany Graphite, a high-purity graphite deposit in Northern Ontario positioned to supply electric vehicle battery anodes, nuclear applications, and advanced materials for North American critical-minerals supply chains. The company leverages centralized regulatory, quality, and commercialization expertise supported by an industrial-scale production facility, while pursuing multiple paths to value creation including product revenue, government contracts, strategic partnerships, and licensing arrangements. Zentek's model emphasizes owning and stewarding intellectual property across graphene-based coatings, aptamer platforms, and high-purity graphite technologies, allocating capital and resources based on risk-adjusted return potential.
Mr. Mohammed Jiwan
24 Corporate Court
Guelph, ON N1G 5G5
Canada
844 730 9822
info@zentek.com
Website →1 Week: -2.44%
1 Month: 3.90%
3 Months: -20.00%
This Year: -10.11%
1 Year: -54.29%
3 Years: -60.40%
5 Years: -69.70%
Symbol: ZENExchange: TSXVCurrency: CAD
52-week low: 0.74
52-week high: 2.50
50-day ma: 0.95
200-day ma: 1.16
Shares Short: 45,748
Short ratio: 0.80
Avg volume: 53,427
Beta: 0.30
86 M
107.54 M
(2025-12-31)
1.8 M
(2025-12-31)
1.9 M
-5.62 M
-1.69 M
0.94 M
0.48 M
0.22%
N/A
0.00%
Login to Dashboard
Copyrights © 2026 Social Tech Nova AB
Disclaimer: Information on GoldSilverAI is for educational purposes only and is not intended as financial advice. Consult a professional advisor before making investment decisions.